ZAPPULO, EMANUELA
 Distribuzione geografica
Continente #
AS - Asia 3.262
NA - Nord America 2.713
EU - Europa 2.181
SA - Sud America 379
AF - Africa 96
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.637
Nazione #
US - Stati Uniti d'America 2.571
SG - Singapore 1.355
RU - Federazione Russa 1.121
VN - Vietnam 744
CN - Cina 625
IT - Italia 370
BR - Brasile 295
HK - Hong Kong 186
NL - Olanda 140
DE - Germania 121
FR - Francia 112
CA - Canada 80
JP - Giappone 66
GB - Regno Unito 65
IN - India 62
FI - Finlandia 56
UA - Ucraina 48
BD - Bangladesh 42
AR - Argentina 38
KR - Corea 38
MX - Messico 37
IE - Irlanda 31
ZA - Sudafrica 27
PL - Polonia 22
CI - Costa d'Avorio 19
IQ - Iraq 19
ES - Italia 18
ID - Indonesia 17
PH - Filippine 16
SE - Svezia 15
TH - Thailandia 14
AT - Austria 13
EC - Ecuador 13
EG - Egitto 11
TW - Taiwan 10
MA - Marocco 9
PK - Pakistan 9
SA - Arabia Saudita 8
TR - Turchia 8
CL - Cile 7
CO - Colombia 7
LT - Lituania 7
DZ - Algeria 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
KE - Kenya 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
BO - Bolivia 4
CH - Svizzera 4
CR - Costa Rica 4
JM - Giamaica 4
LV - Lettonia 4
MK - Macedonia 4
UY - Uruguay 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
AL - Albania 2
AO - Angola 2
BE - Belgio 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
IL - Israele 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BG - Bulgaria 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
ME - Montenegro 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
Totale 8.624
Città #
Singapore 659
San Jose 446
Ashburn 305
Moscow 283
Ho Chi Minh City 197
Hefei 190
Chandler 179
Beijing 171
Hong Kong 171
Hanoi 164
Santa Clara 126
Amsterdam 118
Naples 108
Los Angeles 96
The Dalles 83
Lauterbourg 66
New York 62
Millbury 57
Tokyo 56
Da Nang 43
Munich 39
Dallas 38
Des Moines 37
São Paulo 37
Seoul 32
Napoli 31
Ottawa 31
Haiphong 30
Buffalo 28
Redondo Beach 28
Boston 27
Lawrence 25
Orem 23
Princeton 23
Chicago 22
Frankfurt am Main 22
Seattle 22
Montreal 21
Nanjing 19
Turku 18
Warsaw 18
Boardman 17
Wilmington 17
Brooklyn 15
Can Tho 15
Council Bluffs 15
Nuremberg 15
Chennai 14
Helsinki 14
Rome 14
Biên Hòa 13
Houston 13
Johannesburg 13
Mexico City 13
Phoenix 13
Stockholm 13
Milan 12
Baghdad 11
Denver 11
Hải Dương 11
London 11
Poplar 11
Toronto 11
Atlanta 10
Bologna 9
Charlotte 9
Manchester 9
Porto Alegre 9
Rio de Janeiro 9
Düsseldorf 8
Querétaro 8
Thái Nguyên 8
Cairo 7
City of London 7
Dublin 7
Pune 7
Tân Tiến 7
Bến Tre 6
Fisciano 6
Hebei 6
Nanchang 6
Paris 6
Parma 6
San Francisco 6
Tashkent 6
Thái Bình 6
Tianjin 6
Amman 5
Bangkok 5
Bình Phước 5
Curitiba 5
Da Lat 5
Falkenstein 5
Lappeenranta 5
Madrid 5
New Delhi 5
Ninh Bình 5
Quận Bình Thạnh 5
Washington 5
Boydton 4
Totale 4.681
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 190
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 173
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 159
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 158
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 158
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 153
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 153
Asunaprevir for hepatitis C: A safety evaluation 152
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 150
Diabetes and COVID-19: The potential role of mTOR 149
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 146
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 145
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 141
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 141
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 139
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 137
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 135
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 135
Beclabuvir for the treatment of hepatitis C 135
Trabecular bone score assessed by dual-energy X ray absorption predicts vertebral fractures in HIV infected young adults 134
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 132
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 132
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 131
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 131
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 131
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 130
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 129
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 129
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 129
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 128
Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience 128
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 128
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 128
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 128
Infezione da cytomegalovirus 126
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 126
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 125
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 125
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 124
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 124
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 124
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 122
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 121
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 121
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 120
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 119
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 118
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 118
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 117
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 116
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 114
DNA detection of herpetic viruses in dried blood spots in children with autism spectrum disorders 114
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 114
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 112
Il Virus varicella Zoster 109
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 109
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 107
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 106
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 104
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 100
Epstein-Barr virus 99
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center 98
Prevalence of human herpesvirus-6 and epstein barr virus infections in children with autistic spectrum disorders 97
Response to measles-mumps-rubella vaccine in children with autistic spectrum disorders 97
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 93
Pharmacological approaches to prevent vertical transmission of HIV and HBV 89
HSV 85
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 79
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 71
The role of curcumin in liver diseases 60
No evidence of congenital varicella zoster virus infection assessed through dried blood spot in children with autism spectrum disorders 57
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study) 33
What Drives Mortality in S. maltophilia Bloodstream Infections? An Outcome-Focused Cohort Study of Treatment Strategies and Resistance Profiles 3
Totale 8.793
Categoria #
all - tutte 26.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022290 5 3 3 2 1 12 1 10 27 30 77 119
2022/2023517 51 31 20 35 55 61 14 50 62 114 20 4
2023/2024408 14 65 76 30 22 68 3 35 7 7 43 38
2024/20252.330 85 73 11 43 71 141 213 127 152 268 952 194
2025/20264.814 496 332 579 492 838 218 610 232 541 320 137 19
Totale 8.793